Clin Mol Hepatol.  2017 Dec;23(4):311-313. 10.3350/cmh.2017.0069.

Is it possible to predict the development of an entecavir resistance mutation in patients with chronic hepatitis B in clinical practice?

Affiliations
  • 1Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea. pindra@empal.com, JHLeeMD@gmail.com

Abstract

No abstract available.

Keyword

Chronic hepatitis B; Entecavir; Resistance; Lamivudine

MeSH Terms

Hepatitis B, Chronic*
Hepatitis, Chronic*
Humans
Lamivudine
Lamivudine
Full Text Links
  • CMH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr